OrthoPediatrics KIDS Trauma and deformity — Net revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by OrthoPediatrics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about OrthoPediatrics's trauma and deformity — net revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OrthoPediatrics's trauma and deformity — net revenue?
- OrthoPediatrics (KIDS) reported trauma and deformity — net revenue of $43.05M in Q1 2026.
- How has OrthoPediatrics's trauma and deformity — net revenue changed year-over-year?
- OrthoPediatrics's trauma and deformity — net revenue increased by 13.7% year-over-year, from $37.87M to $43.05M.
- What is the long-term trend for OrthoPediatrics's trauma and deformity — net revenue?
- Over 4 years (2021 to 2025), OrthoPediatrics's trauma and deformity — net revenue has grown at a 26.1% compound annual growth rate (CAGR), from $65.83M to $166.3M.
- What does trauma and deformity — net revenue mean?
- This metric represents the total net sales generated from the company's trauma and deformity product line, which includes specialized implants and surgical instruments designed for pediatric orthopedic procedures. It serves as a primary indicator of market adoption and commercial success for the firm's core surgical solutions. Growth in this revenue stream reflects the company's ability to expand its footprint in the pediatric medical device market and effectively meet the specific clinical needs of surgeons and patients.